Global head speaks on role of insurance in mental health progress
A steady decline in mortality rates since the 19th century has brought about a long-term rise in life expectancy for both men and women, but progress is uneven and, as recent history tells us, uncertain.
This is the third article of a four-part series that will also include an overview and articles further exploring the survey’s implications for product development and claims.
Most underwriting manuals don’t address testosterone and as such underwriting elevated testosterone levels can be murky.
In their most recent white paper, RGA experts Guizhou Hu, Mark Ma, and Taylor Pickett use Milliman risk scores as examples to introduce two risk score accuracy concepts that have been widely documented and applied in statistical literature.
Data scientists from LexisNexis Risk Solutions examined mortality trends before and after the pandemic, especially as those trends pertained to underserved populations. The findings were presented during the Society for Insurance Research’s Annual Conference this week in Cincinnati.
Lauren Garfield explores the increased use of GLP-1 receptor agonist drugs to combat obesity and the potential impact on underwriting.
In late 2022 Gen Re Medical Directors first noticed bizarre ECGs present in PI files from primary insurers. These “perfect” ECGs were performed by paramedical examiners and included with facultative files for reinsurance coverage. Initially they were very rare, but we have seen them become more common.
This article provides background on bladder cancer, with a particular focus on current and in-development treatments for non-muscle-invasive disease.
Raynaud’s phenomenon (or Raynaud’s syndrome) can be part of a much more serious group of impairments which can affect the esophagus, skin and fingers, and progress to gangrene in its more severe form.